File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.biomaterials.2006.11.001
- Scopus: eid_2-s2.0-33845605872
- PMID: 17140655
- WOS: WOS:000243773200014
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Chemical composition, crystal size and lattice structural changes after incorporation of strontium into biomimetic apatite
Title | Chemical composition, crystal size and lattice structural changes after incorporation of strontium into biomimetic apatite |
---|---|
Authors | |
Keywords | Bone crystal Hydroxyapatite Nanocrystallite Strontium-substituted |
Issue Date | 2007 |
Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/biomaterials |
Citation | Biomaterials, 2007, v. 28 n. 7, p. 1452-1460 How to Cite? |
Abstract | Recently, strontium (Sr) as ranelate compound has become increasingly popular in the treatment of osteoporosis. However, the lattice structure of bone crystal after Sr incorporation is yet to be extensively reported. In this study, we synthesized strontium-substituted hydroxyapatite (Sr-HA) with different Sr content (0.3%, 1.5% and 15% Sr-HA in mole ratio) to simulate bone crystals incorporated with Sr. The changes in chemical composition and lattice structure of apetite after synthetic incorporation of Sr were evaluated to gain insight into bone crystal changes after incorporation of Sr. X-ray diffraction (XRD) patterns revealed that 0.3% and 1.5% Sr-HA exhibited single phase spectrum, which was similar to that of HA. However, 15% Sr-HA induced the incorporation of HPO 4 2- and more CO 3 2-, the crystallinity reduced dramatically. Transmission electron microscopy (TEM) images showed that the crystal length and width of 0.3% and 1.5% Sr-HA increased slightly. Meanwhile, the length and width distribution were broadened and the aspect ratio decreased from 10.68±4.00 to 7.28±2.80. The crystal size and crystallinity of 15% Sr-HA dropped rapidly, which may suggest that the fundamental crystal structure is changed. The findings from this work indicate that current clinical dosage which usually results in Sr incorporation of below 1.5% may not change chemical composition and lattice structure of bone, while it will broaden the bone crystal size distribution and strengthen the bone. © 2006 Elsevier Ltd. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/79383 |
ISSN | 2023 Impact Factor: 12.8 2023 SCImago Journal Rankings: 3.016 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, ZY | en_HK |
dc.contributor.author | Lam, WM | en_HK |
dc.contributor.author | Yang, C | en_HK |
dc.contributor.author | Xu, B | en_HK |
dc.contributor.author | Ni, GX | en_HK |
dc.contributor.author | Abbah, SA | en_HK |
dc.contributor.author | Cheung, KMC | en_HK |
dc.contributor.author | Luk, KDK | en_HK |
dc.contributor.author | Lu, WW | en_HK |
dc.date.accessioned | 2010-09-06T07:54:04Z | - |
dc.date.available | 2010-09-06T07:54:04Z | - |
dc.date.issued | 2007 | en_HK |
dc.identifier.citation | Biomaterials, 2007, v. 28 n. 7, p. 1452-1460 | en_HK |
dc.identifier.issn | 0142-9612 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/79383 | - |
dc.description.abstract | Recently, strontium (Sr) as ranelate compound has become increasingly popular in the treatment of osteoporosis. However, the lattice structure of bone crystal after Sr incorporation is yet to be extensively reported. In this study, we synthesized strontium-substituted hydroxyapatite (Sr-HA) with different Sr content (0.3%, 1.5% and 15% Sr-HA in mole ratio) to simulate bone crystals incorporated with Sr. The changes in chemical composition and lattice structure of apetite after synthetic incorporation of Sr were evaluated to gain insight into bone crystal changes after incorporation of Sr. X-ray diffraction (XRD) patterns revealed that 0.3% and 1.5% Sr-HA exhibited single phase spectrum, which was similar to that of HA. However, 15% Sr-HA induced the incorporation of HPO 4 2- and more CO 3 2-, the crystallinity reduced dramatically. Transmission electron microscopy (TEM) images showed that the crystal length and width of 0.3% and 1.5% Sr-HA increased slightly. Meanwhile, the length and width distribution were broadened and the aspect ratio decreased from 10.68±4.00 to 7.28±2.80. The crystal size and crystallinity of 15% Sr-HA dropped rapidly, which may suggest that the fundamental crystal structure is changed. The findings from this work indicate that current clinical dosage which usually results in Sr incorporation of below 1.5% may not change chemical composition and lattice structure of bone, while it will broaden the bone crystal size distribution and strengthen the bone. © 2006 Elsevier Ltd. All rights reserved. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/biomaterials | en_HK |
dc.relation.ispartof | Biomaterials | en_HK |
dc.rights | Biomaterials. Copyright © Elsevier BV. | en_HK |
dc.subject | Bone crystal | en_HK |
dc.subject | Hydroxyapatite | en_HK |
dc.subject | Nanocrystallite | en_HK |
dc.subject | Strontium-substituted | en_HK |
dc.title | Chemical composition, crystal size and lattice structural changes after incorporation of strontium into biomimetic apatite | en_HK |
dc.type | Article | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0142-9612&volume=28&issue=7&spage=1452&epage=60&date=2007&atitle=Chemical+composition,+crystal+size+and+lattice+structural+changes+after+incorporation+of+strontium+into+biomimetic+apatite | en_HK |
dc.identifier.email | Cheung, KMC:cheungmc@hku.hk | en_HK |
dc.identifier.email | Luk, KDK:hcm21000@hku.hk | en_HK |
dc.identifier.email | Lu, WW:wwlu@hku.hk | en_HK |
dc.identifier.authority | Cheung, KMC=rp00387 | en_HK |
dc.identifier.authority | Luk, KDK=rp00333 | en_HK |
dc.identifier.authority | Lu, WW=rp00411 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.biomaterials.2006.11.001 | en_HK |
dc.identifier.pmid | 17140655 | - |
dc.identifier.scopus | eid_2-s2.0-33845605872 | en_HK |
dc.identifier.hkuros | 137131 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-33845605872&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 28 | en_HK |
dc.identifier.issue | 7 | en_HK |
dc.identifier.spage | 1452 | en_HK |
dc.identifier.epage | 1460 | en_HK |
dc.identifier.isi | WOS:000243773200014 | - |
dc.publisher.place | Netherlands | en_HK |
dc.identifier.scopusauthorid | Li, ZY=35784563200 | en_HK |
dc.identifier.scopusauthorid | Lam, WM=13403256300 | en_HK |
dc.identifier.scopusauthorid | Yang, C=55223257000 | en_HK |
dc.identifier.scopusauthorid | Xu, B=24752310700 | en_HK |
dc.identifier.scopusauthorid | Ni, GX=8303037400 | en_HK |
dc.identifier.scopusauthorid | Abbah, SA=14032930600 | en_HK |
dc.identifier.scopusauthorid | Cheung, KMC=7402406754 | en_HK |
dc.identifier.scopusauthorid | Luk, KDK=7201921573 | en_HK |
dc.identifier.scopusauthorid | Lu, WW=7404215221 | en_HK |
dc.identifier.issnl | 0142-9612 | - |